Skip to main content
July 7, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Patritumab Deruxtecan (HER3-DXd)
Bladder Cancer Treatment
Patritumab Deruxtecan Shows Promise in HER3-Expressing Metastatic Breast Cancer
By Dr. C.H. Weaver M.D.
Jun 13, 2022
CLOSE
CLOSE
CLOSE
CLOSE